Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of septic shock.

Jean-Louis Vincent1, Frederico Bruzzi de Carvalho, Daniel De Backer

  • 1Department of Intensive Care, Erasme Hospital, Free University of Brussels, Route de Lennik 80, B-1070 Brussels, Belgium. jlvincen@ulb.ac.be

Annals of Medicine
|January 30, 2003
PubMed
Summary

Severe sepsis and septic shock are serious conditions impacting hospital admissions and ICU costs. New treatments, like drotrecogin alfa, are improving patient outcomes by targeting the sepsis response.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is Early Vasopressor Administration Really Not Important in Septic Shock?

Annals of emergency medicine·2026
Same author

The role of hemoadsorption in septic shock: toward a personalized approach.

Critical care (London, England)·2026
Same author

The new SOFA for sepsis identification and mortality prediction: a multicenter cohort study.

Journal of intensive care·2026
Same author

The IMPACT framework for evaluating generative AI in critical care: development and multinational consensus validation.

Annals of intensive care·2026
Same author

European Society of Intensive Care Medicine Clinical Practice Guideline on fluid therapy in adult critically ill patients: A path toward improved patient management.

Journal of intensive medicine·2026
Same author

Delayed presentation of air embolism after removal of central venous catheters: A systematic review.

Journal of critical care·2026

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Severe sepsis and septic shock represent a significant cause of hospital admissions in the US, leading to substantial morbidity, mortality, and intensive care unit (ICU) costs.
  • Traditional management focused on antimicrobial therapy, source control, and organ support.
  • Recent advancements in understanding sepsis pathophysiology have paved the way for novel therapeutic interventions.

Purpose of the Study:

  • To review the evolving understanding of severe sepsis and septic shock management.
  • To highlight the impact of new therapeutic approaches, specifically drotrecogin alfa, on patient outcomes.

Main Methods:

  • Review of recent literature on sepsis pathophysiology and treatment.
  • Analysis of the role of drotrecogin alfa in severe sepsis management.

Main Results:

  • Drotrecogin alfa has demonstrated a specific reduction in mortality for patients with severe sepsis.
  • Intensive early resuscitation remains critical, complemented by new management strategies.

Conclusions:

  • New therapeutic agents like drotrecogin alfa are transforming severe sepsis care.
  • Integration of novel approaches into sepsis management protocols promises improved patient outcomes.

Related Experiment Videos